Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: Final results of JCOG0205
-
Published:2014-09
Issue:13
Volume:50
Page:2231-2240
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Shimada YasuhiroORCID,
Hamaguchi Tetsuya,
Mizusawa Junki,
Saito Norio,
Kanemitsu Yukihide,
Takiguchi Nobuhiro,
Ohue Masayuki,
Kato Takeshi,
Takii Yasumasa,
Sato Toshihiko,
Tomita Naohiro,
Yamaguchi Shigeki,
Akaike Makoto,
Mishima Hideyuki,
Kubo Yoshiro,
Nakamura Kenichi,
Fukuda Haruhiko,
Moriya Yoshihiro
Subject
Cancer Research,Oncology
Reference19 articles.
1. Cancer statistics in Japan. Available at: ; 2012 [accessed on 21st April, 2014] [in Japanese].
2. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer;André;N Engl J Med,2004
3. Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses;Yothers;J Clin Oncol,2011
4. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer;Haller;J Clin Oncol,2011
5. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial;André;J Clin Oncol,2009
Cited by
106 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献